FluTrends’ premier flu-prevention solution soon to be available in Mexico

Reston, VA, July 8, 2011 — FluTrends International Corporation has received regulatory approval and will be able to import and commercialize their new flu-prevention product  in Mexico before the end of the year.

This approval would allow Mexico and other South American countries access to the new product through various South American Trade Agreements. It would be sold as a dietary supplement, which means that it would not require a prescription and would increase people’s access.

“People need choices,” says Founder and Chief Medical Officer, Dr. Steven Schwartz. “We are honored to be able to help and make an impact.”

As part of their global initiative to prevent the spread of influenza, FluTrends is committed to providing protection, solutions and services as they work towards a definitive cure. Their new product in achieving this goal is a convenient, naturally-derived nasal and throat spray that provides year-round prevention from the flu virus. This product is positioned to provide an additional option to compliment other vaccines, as well as an alternative to the DNA-based universal vaccine currently in development.

FluTrends was founded in 2009 to fulfill its mission of saving lives, reducing morbidity and lessening the economic impact of influenza with the intent to eliminate it in the next decade. It is dedicated to the development and commercialization of flu-prevention products through a multi-layered program using research, biotechnology and personal protection. The long-term goal is to prevent potential pandemics and ultimately eradicate influenza with a definitive cure. Company headquarters are located in Reston, VA with research facilities in Denver, CO.

Contact:
Christopher Nelson, CFO
FluTrends International Corporation
11710 Plaza America Drive, Suite 950
Reston, Virginia 20190
P: (303) 974-7510
www.flutrends.com